TY - JOUR
T1 - Medicinal Mushrooms in Colon Cancer Therapy
T2 - Mechanisms of Action of Bioactive Compounds and Therapeutic Potential
AU - Bentharavithana, Jinangi
AU - Islam, Tahidul
AU - Xu, Baojun
N1 - Publisher Copyright:
© 2025 by the authors.
Funding Information:
This work was jointly supported by the Guangdong Higher Education Upgrading Plan (2021–2025) under grant nos. UICR0400015-24B and UICR0400016-24B at Beijing Normal-Hong Kong Baptist University, Zhuhai, China.
PY - 2025/5/31
Y1 - 2025/5/31
N2 - Colon cancer is the second leading cause of cancer-related deaths in the
world. This is commonly observed among older adults, and the occurrence
of colon cancer is mainly influenced by unhealthy lifestyle factors.
Edible medicinal mushrooms have been demonstrated to have anti-colon
cancer effects both individually and in combination with conventional
therapies, including synergistically enhancing the efficacy of
chemotherapy medications such as 5-fluorouracil in preclinical models.
Medicinal mushrooms such as Lentinus edodes, Phellinus linteus, Ganoderma lucidum, Inonotus obliquus, Pleurotus ostreatus, Hericium erinaceus, Pleurotus eryngii, Gloeostereum incarnatum, and Termitomyces heimii
are emerging as promising candidates, not only because conventional
treatments for colon cancer face significant limitations, including side
effects, psychological impacts on patients, high cost, limited
specificity toward cancer and healthy cells, and the development of drug
resistance, but also due to the diverse array of bioactive compounds
present within them. Therefore, there is a strong demand for innovative,
affordable, and minimally invasive treatments such as medicinal
mushrooms. Their bioactive compounds, including terpenoids, sterols,
phenols, polysaccharides, acids, sesquiterpenes, alkaloids, lactones,
metal-chelating agents, nucleotide analogs, glycoproteins, β-glucan,
cerebrosides, steroids, terpenes, quinolones, anthraquinones, benzoic
acid derivatives, linoleic acid, ascorbic acid, glycosides, organic
acids, flavonoids, grifolin, tocopherols, proteins, indoles, lectin, and
laccases, exert anti-colon cancer activities through various
mechanisms, including anti-proliferative effects, cell cycle arrest,
anti-inflammatory effects, antioxidant effects, induction of apoptosis,
cytotoxic effects, and antimigratory effects. Further research is needed
to elucidate the molecular mechanisms and confirm the safety and
efficacy of medicinal mushrooms as a holistic anti-colon cancer
treatment.
AB - Colon cancer is the second leading cause of cancer-related deaths in the
world. This is commonly observed among older adults, and the occurrence
of colon cancer is mainly influenced by unhealthy lifestyle factors.
Edible medicinal mushrooms have been demonstrated to have anti-colon
cancer effects both individually and in combination with conventional
therapies, including synergistically enhancing the efficacy of
chemotherapy medications such as 5-fluorouracil in preclinical models.
Medicinal mushrooms such as Lentinus edodes, Phellinus linteus, Ganoderma lucidum, Inonotus obliquus, Pleurotus ostreatus, Hericium erinaceus, Pleurotus eryngii, Gloeostereum incarnatum, and Termitomyces heimii
are emerging as promising candidates, not only because conventional
treatments for colon cancer face significant limitations, including side
effects, psychological impacts on patients, high cost, limited
specificity toward cancer and healthy cells, and the development of drug
resistance, but also due to the diverse array of bioactive compounds
present within them. Therefore, there is a strong demand for innovative,
affordable, and minimally invasive treatments such as medicinal
mushrooms. Their bioactive compounds, including terpenoids, sterols,
phenols, polysaccharides, acids, sesquiterpenes, alkaloids, lactones,
metal-chelating agents, nucleotide analogs, glycoproteins, β-glucan,
cerebrosides, steroids, terpenes, quinolones, anthraquinones, benzoic
acid derivatives, linoleic acid, ascorbic acid, glycosides, organic
acids, flavonoids, grifolin, tocopherols, proteins, indoles, lectin, and
laccases, exert anti-colon cancer activities through various
mechanisms, including anti-proliferative effects, cell cycle arrest,
anti-inflammatory effects, antioxidant effects, induction of apoptosis,
cytotoxic effects, and antimigratory effects. Further research is needed
to elucidate the molecular mechanisms and confirm the safety and
efficacy of medicinal mushrooms as a holistic anti-colon cancer
treatment.
KW - apoptosis
KW - bioactive compounds
KW - clinical study
KW - edible mushrooms
KW - medicinal mushrooms
UR - http://www.scopus.com/inward/record.url?scp=105007788785&partnerID=8YFLogxK
U2 - 10.3390/ijms26115304
DO - 10.3390/ijms26115304
M3 - Journal article
AN - SCOPUS:105007788785
SN - 1661-6596
VL - 26
JO - International Journal of Molecular Sciences
JF - International Journal of Molecular Sciences
IS - 11
M1 - 5304
ER -